Biomarker World Congress 2010

Philadelphia, Pennsylvania



   Each year, CHI organizes OVER 100 ANNUAL EVENTS geared to the biotech
   and pharmaceutical industries with specific FOCUSES ON:

    Proteins and Proteomics
    Drug Discovery & Development
    IT and Informatics
    Diagnostics & Safety



   May 4-6, 2010
   Philadelphia, Pennsylvania

   For a comprehensive conference listing and detailed information about
   our products and services, please visit:

   Cambridge Healthtech Institute
   250 First Avenue, Suite 300, Needham, MA 02494, USA
   Telephone: 781-972-5400 or Toll-free in the U.S. 888-999-6288
   Fax: 781-972-5425

Schedule of Presentations:

Tuesday, May 4, 2010
08:00:00 Registration for Pre-Conference Events
08:30:00 Pre-Conference Short Course*
08:35:00 Fit-For-Purpose Biomarker Assay Development and Validation* John L. Allinson, Viswanath Devanarayan
12:00:00 Main Conference Registration
13:00:00 Welcoming Remarks from Conference Director Julia Boguslavsky
13:10:00 Implementing Personalized Medicine
13:15:00 New Era with Targeted Drugs: New Development Approaches are Needed to Achieve Success Geert J.C.M. Kolvenbag
13:45:00 Evolutionary Genetics of Alzheimer’s Disease Allen D. Roses
14:15:00 Applied Biomarkers: The Role of Benefit Management in Translating Personalized Medicine from Research to Practice Felix Frueh
14:45:00 Biomarkers and the Development of Personalized Medicine: A Regulatory Perspective Francis Kalush
15:15:00 Networking Refreshment Break
15:55:00 Translational Medicine
16:00:00 Translational Medicine: The “Do or Die” for the Pharmaceutical Industry Giora Feuerstein
16:30:00 Identification of a Transcriptional Biomarker of Target Engagement and Use in Oncology Early Clinical Development Samuel C. Blackman
17:00:00 Opening Reception with Exhibit and Poster Viewing
Wednesday, May 5, 2010
07:00:00 Registration Open
07:30:00 Breakfast Presentation
07:35:00 Classification of Alcohol Abuse by Plasma Protein Biomarkers Willard M Freeman
08:20:00 Circulating Tumor Cells
08:25:00 Chairperson’s Opening Remarks
08:30:00 Circulating Tumor Cells (CTCs) in Breast Cancer: Use of Novel Diagnostics to Define the Metastatic Process Massimo Cristofanilli
09:00:00 Circulating Tumor Cells in Drug Development Robert McCormack
09:30:00 Coffee Break with Exhibit and Poster Viewing
10:25:00 TECHNOLOGY SHOWCASE I: Biomarker Discovery, Qualification and Development
10:30:00 Quantification of Small Molecule Steroid Biomarkers Using LC-MS/MS Richard Houghton
11:00:00 The Changing Information Trends of Biomarker Research Mike Willey
11:15:00 Comprehensive Metabolomics for Identification and Validation of Novel Biomarkers Christopher Macri
11:30:00 Sponsored Presentation
12:00:00 Design and Produce Antibodies for Biomarker Studies with Antigen Profiler Matt Baker
12:30:00 Lunch on your own
13:55:00 Clinical Applications of Biomarkers
14:00:00 Role of Biomarkers in Drug Development: Application in Late Phase Clinical Trials Yaning Wang
14:30:00 Impact of Biomarkers on Clinical Development Shabnam Tangri
15:00:00 Are We Close to Personalizing the Choice of BCR-ABL Inhibitor Therapy for CML Patients? Yaping Shou
15:30:00 Refreshment Break with Exhibit and Poster Viewing
16:30:00 Molecular Insight into Metastatic Potential and Response to Tamoxifen in Breast Cancer Andrew Grupe
17:00:00 Lymphatic Mapping and Realtime Molecular Biomarker Upstaging of Melanoma Sentinel Lymph Node(s) Dave S. B. Hoon
17:30:00 Biomarkers to Access Immune Status Aaron B. Kantor
18:00:00 Close of Day
Thursday, May 6, 2010
06:00:00 Renal Safety Biomarker Qualification: A Collaboration between the Biomarkers Consortium and the Critical Path Institute David Wholley
07:30:00 Breakfast Presentation (Opportunity Available) or Morning Coffee
08:15:00 Overcoming Barriers in Biomarker Implementation
08:30:00 Medicare Faces Biomarkers: What to Expect in the Next Decade Bruce Quinn
09:00:00 Biomarker Validation: Evaluating the Evidence Margaret Piper
09:30:00 Coffee Break with Exhibit and Poster Viewing
10:30:00 Biomarkers to Accelerate Drug Development
10:35:00 Biomarker Practice in Early Development Hans Winkler
11:00:00 Pre-clinical Translational Biomarkers: Enabling Early Predictions Using PK/PD Mark Fidock
11:30:00 Applications of Traditional and Nontraditional Toxicity End-Points in the in vitro Mechanistic Toxicology Studies Madhu Mondal
12:00:00 From Biomarker Strategies to Biomarker Activities and Back Alain van Gool
12:30:00 Luncheon Presentation New Approaches Have Significant Impact on Biomarker Discovery and ValidationSponsored Daniel Chelsky
14:00:00 Collaborative Efforts in Biomarker Development
14:30:00 Practice and Pitfalls of Open Source Precompetitive Collaboration on Biomarkers John A. Wagner
15:00:00 The SAFE-T Consortium: Qualification of Translational Biomarkers for the Kidney, Liver and Vascular System Joe Keenan
15:30:00 Close of Conference
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.